Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sublingual immunotherapy: update 2006.

Giovanni Passalacqua1, Giorgio Walter Canonica

  • 1Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy. passalacqua@unige.it

Current Opinion in Allergy and Clinical Immunology
|November 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrastructural Mucosal Response to Dupilumab in Chronic Rhinosinusitis With Nasal Polyps: A Pilot Study.

Clinical and translational allergy·2026
Same author

Clinical Evaluation of Allergen Immunotherapy for Allergic Rhinitis.

Vaccines·2026
Same author

The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA<sup>2</sup>LEN ADCARE statement paper.

The World Allergy Organization journal·2026
Same author

Three years treatment with HDM allergen immunotherapy, omalizumab, or combination therapy in allergic asthma: clinical outcomes and biomarkers.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Geographical variability in severe asthma: comparison of patients' characteristics between national, regional, and international cohorts in ISAR.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Allergic rhinitis activity and efficacy of 300 IR house dust mite sublingual immunotherapy tablet in pediatrics.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Sublingual immunotherapy (SLIT) is a safe and effective treatment for allergies, preventing new sensitizations and asthma. Recent data confirm SLIT

Area of Science:

  • Allergen immunotherapy
  • Clinical immunology
  • Respiratory medicine

Background:

  • Sublingual immunotherapy (SLIT) is an established allergy treatment, particularly in Europe.
  • Recent research has focused on clinical, immunological, and practical aspects of SLIT.
  • New data address critical points and expand understanding of SLIT's role.

Purpose of the Study:

  • To review and synthesize recent findings on sublingual immunotherapy.
  • To evaluate the clinical efficacy and safety of SLIT.
  • To explore immunological mechanisms and practical considerations of SLIT.

Main Methods:

  • Review of recently published clinical studies and postmarketing surveys.
  • Analysis of data on efficacy, safety, compliance, and immunological effects.

Related Experiment Videos

  • Investigation of allergen biodistribution and mechanisms of action.

    • Main Results:

    • SLIT demonstrates clinical efficacy, preventing new sensitizations and asthma, similar to injection routes.
    • Postmarketing surveys confirm a favorable safety profile, even in young children, with good compliance.
    • Studies suggest SLIT can be administered without an updosing phase, and mechanisms of action are clarified.

    Conclusions:

    • Sublingual immunotherapy is a valuable and viable therapeutic option for allergic diseases.
    • Emerging data consistently support the effectiveness and utility of SLIT.
    • SLIT represents a significant advancement in allergy management.